Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-31

Clinical Trial Update: Aerobic Exercise for Remyelination in Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating aerobic exercise as a potential strategy to promote remyelination in people with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Multiple Sclerosis, Sclerosis | Phase 1, Phase 2 | Status: COMPLETED